http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002300884-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1010e3862914acdd087e73d76911ec6d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 |
| filingDate | 2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b3aeca3d9d9a25624a3be62220225b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_846ad9183791c8f94599876bbc60154e |
| publicationDate | 2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002300884-A |
| titleOfInvention | Antisense oligonucleotide having an effect of suppressing drebrin A expression |
| abstract | PROBLEM TO BE SOLVED: To provide an antisense oligonucleotide which can be expected to be useful as a therapeutic agent for fragile X syndrome or the like and which can specifically suppress the expression of drebrin A. SOLUTION: aggcatcggacaggtgggcctctct of an ins2 region which is specifically present in drebrin A and whose sequence is well conserved across animal species. 24-mer S-oligo (5'-AGGAAGGCCCCACTGTC which is the antisense strand of (SEQ ID NO: 5) CGATGCCT-3 ′), an antisense oligonucleotide that hybridizes with the base sequence shown in SEQ ID NO: 5 under stringent conditions and has an effect of suppressing drebrin A expression, and derivatives thereof. |
| priorityDate | 2001-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 376.